Histology
Non-Small Cell Carcinoma
CI-CAN-00001292Explore in graph →
1,752 active trials47 approved drugs589 evidence items
- NCIt
- C65151
Loading cancer entity…
Loading cancer entity…
Histology
CI-CAN-00001292Explore in graph →
Clinical trials
6,757 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,046)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01687439 | Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 15 | Fudan UniversityOTHER | 1 | Sep 19, 2012 | clinicaltrials |
| NCT00991796 | CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 109 | Daiichi SankyoINDUSTRY | 1 | Sep 10, 2012 | clinicaltrials |
| NCT01167972 | Observational Study on the Management of Patients With Non Small Cell Lung Cancer Adenocarcinoma(MUTACT) | completed | — | 2,000 | AstraZenecaINDUSTRY | 1 | Sep 10, 2012 | clinicaltrials |
| NCT01067794 | Chemotherapy in Treating Patients With Lung Cancer(FRAME) | completed | — | 1,610 | Eli Lilly and CompanyINDUSTRY | 0 | Aug 24, 2012 | clinicaltrials |
| NCT00988936 | Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug(K5-101) | completed | Phase 2 | 35 | Siemens Molecular ImagingINDUSTRY | 1 | Aug 22, 2012 | clinicaltrials |
| NCT00707304 | Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer(FORTIS-M) | completed | Phase 3 | 742 | AgennixINDUSTRY | 23 | Aug 21, 2012 | clinicaltrials |
| NCT00085839 | Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2 | completed | Phase 2 | 103 | OSI PharmaceuticalsINDUSTRY | 1 | Aug 9, 2012 | clinicaltrials |
| NCT00294762 | Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC | completed | Phase 2 | 143 | OSI PharmaceuticalsINDUSTRY | 2 | Aug 9, 2012 | clinicaltrials |
| NCT00680940 | A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer(NSCLC) | completed | Phase 2 | 221 | Cadila PharnmaceuticalsINDUSTRY | 1 | Aug 7, 2012 | clinicaltrials |
| NCT00910676 | Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors(DIPROCOL) | completed | Phase 2 | 30 | Centre Oscar LambretOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00050960 | Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer | completed | Phase 3 | 612 | Eisai Inc.INDUSTRY | 6 | Jul 13, 2012 | clinicaltrials |
| NCT00401492 | MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung Cancer | completed | Phase 2 | 159 | National Cancer Institute, NaplesOTHER | 0 | Jul 13, 2012 | clinicaltrials |
| NCT00890903 | Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC) | completed | — | 62 | Pierre Fabre Pharma GmbHINDUSTRY | 1 | Jul 2, 2012 | clinicaltrials |
| NCT01023828 | K-RAS Oncogene Mutation in Patients With Advanced Non-Small Cell Lung Cancer Associated With Exposure to Wood Smoke and Tobacco Smoking: Therapeutic Implications(007/055/OMI) | completed | — | 150 | National Institute of CancerologíaOTHER_GOV | 1 | Jun 29, 2012 | clinicaltrials |
| NCT00826878 | An Open-Label Study of QD Oral Administration of Tivozanib (AV-951) in Subjects With Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 1 | 17 | AVEO Pharmaceuticals, Inc.INDUSTRY | 1 | Jun 28, 2012 | clinicaltrials |
| NCT00094094 | Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 32 | PfizerINDUSTRY | 2 | Jun 26, 2012 | clinicaltrials |
| NCT00887549 | A Study of Thymidylate Synthase Expression in Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 70 | Eli Lilly and CompanyINDUSTRY | 2 | Jun 19, 2012 | clinicaltrials |
| NCT00367679 | Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer | completed | Phase 2 | 35 | GlaxoSmithKlineINDUSTRY | 3 | Jun 12, 2012 | clinicaltrials |
| NCT00312975 | Randomized Study Of CP-675,206 or Best Supportive Care Immediately After Platinum-Based Therapy For Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 90 | AstraZenecaINDUSTRY | 5 | Jun 7, 2012 | clinicaltrials |
| NCT00478049 | Iressa as Second Line Therapy in Advanced NSCLC-Asia(ISTANA) | completed | Phase 3 | 163 | AstraZenecaINDUSTRY | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00745875 | ZD4054 (Zibotentan) Phase II Non-Small Cell Lung Cancer Study | completed | Phase 2 | 66 | AstraZenecaINDUSTRY | 5 | Jun 6, 2012 | clinicaltrials |
| NCT00088556 | Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 100 | TelikINDUSTRY | 1 | May 31, 2012 | clinicaltrials |
| NCT00330746 | CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung Cancer(CALC-1) | completed | Phase 2 | 100 | National Cancer Institute, NaplesOTHER | 1 | May 18, 2012 | clinicaltrials |
| NCT00251446 | A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 70 | Veeda OncologyOTHER | 1 | May 11, 2012 | clinicaltrials |
| NCT00251524 | A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC | completed | Phase 2 | 69 | Veeda OncologyOTHER | 1 | May 11, 2012 | clinicaltrials |
| NCT00098254 | BAY 43-9006 (Sorafenib) to Treat Relapsed Non-Small Cell Lung Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | May 2, 2012 | clinicaltrials |
| NCT00268970 | Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 40 | AgennixINDUSTRY | 1 | Apr 30, 2012 | clinicaltrials |
| NCT00807066 | Randomized Gefitinib Trial(RANGE) | completed | Phase 3 | 1 | Fondazione Humanitas per la RicercaOTHER | 1 | Apr 23, 2012 | clinicaltrials |
| NCT01581346 | Exercise Study in Patients With Lung Cancer(POSITIVE) | completed | Phase 2 | 40 | German Cancer Research CenterOTHER | 1 | Apr 20, 2012 | clinicaltrials |
| NCT00652340 | APRiCOT-L: Study to Evaluate Efficacy and Safety of Apricoxib With Erlotinib in Patients With Non-small Cell Lung Cancer(TP2001-201) | completed | Phase 2 | 120 | Tragara Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 9, 2012 | clinicaltrials |
| NCT00692640 | Safety Study of XL147 (SAR245408) in Combination With Erlotinib in Adults With Solid Tumors | completed | Phase 1 | 35 | SanofiINDUSTRY | 1 | Mar 23, 2012 | clinicaltrials |
| NCT00442754 | Dendritic Cells in Lung Cancer | completed | Phase 2 | 50 | Herlev HospitalOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT00517595 | Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC | completed | Phase 2 | 48 | Accelerated Community Oncology Research NetworkOTHER | 1 | Mar 12, 2012 | clinicaltrials |
| NCT00816868 | A Phase II Study of TX Regimen as First-line Treatment for Asian Elderly Patients With Advanced Adenocarcinoma of Lung | completed | Phase 2 | 62 | Sun Yat-sen UniversityOTHER | 1 | Mar 1, 2012 | clinicaltrials |
| NCT00432562 | A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer. | completed | Phase 1 | 31 | Mast Therapeutics, Inc.INDUSTRY | 1 | Feb 23, 2012 | clinicaltrials |
| NCT00034957 | Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC) | completed | Phase 2 | — | PfizerINDUSTRY | 1 | Feb 16, 2012 | clinicaltrials |
| NCT01270386 | A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer | completed | Phase 2 | 136 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Feb 10, 2012 | clinicaltrials |
| NCT00138658 | A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 85 | Achieve Life SciencesINDUSTRY | 2 | Feb 6, 2012 | clinicaltrials |
| NCT00777699 | Safety Study of XL765 (SAR245409) in Combination With Erlotinib in Adults With Solid Tumors | completed | Phase 1 | 80 | SanofiINDUSTRY | 1 | Feb 3, 2012 | clinicaltrials |
| NCT00408226 | Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 27 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Jan 20, 2012 | clinicaltrials |
| NCT01260038 | Study in NSCLC: is Timely Analysis of EGFR-mutation Status Feasible in Region Antwerp, Belgium.(HERMES) | completed | — | 107 | University Hospital, AntwerpOTHER | 1 | Jan 18, 2012 | clinicaltrials |
| NCT01083589 | Imatinib Mesylate and Docetaxel in Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 22 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 11, 2012 | clinicaltrials |
| NCT01065415 | Whole-Body Magnetic Resonance Imaging/Positron Emission Tomography (MRI/PET) in the Staging of Non-Small-Cell Lung Cancer (NSCLC) | completed | — | 272 | Samsung Medical CenterOTHER | 1 | Dec 29, 2011 | clinicaltrials |
| NCT00606021 | A Study Comparing of Two Different Chemotherapy Regimens, in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer | completed | Phase 2 | 106 | Eli Lilly and CompanyINDUSTRY | 3 | Dec 26, 2011 | clinicaltrials |
| NCT01494558 | Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung Cancer | completed | Phase 2 / Phase 3 | 200 | Chinese Academy of Medical SciencesOTHER | 0 | Dec 19, 2011 | clinicaltrials |
| NCT01222312 | Study for Therapy of Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) With Cisplatin / Docetaxel or Oxaliplatin / Docetaxel(Taxelox) | completed | Phase 2 | 88 | Krankenhaus NordwestOTHER | 1 | Nov 29, 2011 | clinicaltrials |
| NCT00136864 | Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial) | completed | Phase 3 | 310 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Nov 18, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Sep 19, 2012source: clinicaltrials